Organigram Posts Record Q3 on Sanity Acquisition Boost
Event summary
- Q3 net revenue up 49% YoY to $105.8M, driven by Sanity acquisition.
- Adjusted EBITDA surged 136% YoY to $13.4M on operational efficiencies.
- Sanity contributed €25M (C$40M) in net revenue since April 2026.
- Market share leadership: #1 in vapes, milled flower, and concentrates.
- Free cash flow turned negative ($3.9M outflow) due to working capital growth.
The big picture
Organigram's record quarter underscores the strategic value of its European expansion through Sanity, but operational execution and cash flow management will determine whether this growth is sustainable. The cannabis sector's consolidation trend continues as vertically integrated players like Organigram leverage acquisitions to scale globally.
What we're watching
- Integration Risk
- Whether Sanity's performance can sustain current growth trajectory.
- Cash Flow Dynamics
- The pace at which working capital investments normalize free cash flow.
- Market Share Defense
- How Organigram maintains leadership in key Canadian categories amid competition.
Related topics